trending Market Intelligence /marketintelligence/en/news-insights/trending/-vI2nt5vak7-Ec8F9cGeSA2 content esgSubNav
In This List

Medtronic secures US FDA approval for glucose monitoring device

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Medtronic secures US FDA approval for glucose monitoring device

Medtronic PLC said the U.S. Food and Drug Administration approved its Guardian monitoring system, which alerts diabetes patients of potential high or low glucose events up to 60 minutes in advance.

The glucose monitoring system is approved for diabetes patients 14-75 years old.

The Dublin-based medical device maker said its product will be available in the first quarter of fiscal 2019.